First Manhattan »

Neubase Therapeutics shares owned by First Manhattan

Quarter-by-quarter ownership of Neubase Therapeutics (NBSE) shares owned by First Manhattan from 13F filings

Historical chart of First Manhattan investment in Neubase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neubase Therapeutics held by First Manhattan consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neubase Therapeutics by First Manhattan

Quarter filed Position value Share count Share price at filing
2024-03-31 $158 353 0.45
2023-09-30 $614 706 0.87
2023-06-30 $1.3k 706 1.87